Updates in Upper GI Cancers From ASCO and ASCO GI 2024 - Episode 4

Long-Term Data for Frontline Nivolumab Plus Chemo or Ipilimumab in Advanced ESCC

,

Samuel Cytryn, MD, and David B. Zhen, MD, on long-term data for nivolumab plus chemotherapy or ipilimumab in advanced esophageal squamous cell carcinoma.